Infective Endocarditis in End Stage Kidney Disease

What is it about?

This paper investigates the incidence and risk factors of infective endocarditis in a nationwide population of end stage kidney disease patients in renal replacement therapy (hemodialysis, peritoneal dialysis, kidney transplanted).

Featured Image

Why is it important?

Infectious diseases remain the second leading cause of death in patients in renal replacement therapy. Infective endocarditis contributes to mortality and morbidity in end stage kidney disease patients in renal replacement therapy. Our findings demonstrate an increased risk of infective endocarditis in hemodialysis patients with central venous catheters. Thus, it is of major importance to limit the use of central venous catheters in an attempt to avoid infective endocarditis.